HomeACADEMIA
ACADEMIA

Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist
(Sep.21.2018)

Dr. Takumi Kishimoto
Takumi Kishimoto, director of the Japan Organization of Occupational Health and Safety’s asbestos-related diseases research center, welcomed the expanded indication for malignant pleural mesothelioma granted to the PD-1 inhibitor Opdivo (nivolumab), which became a new treatment option for the disease in 11 years ...
(LOG IN FOR FULL STORY)